Diagnostics company teams up with frontrunner
Medical Prognosis Institute, which has developed an algorithm that can help target medicine to the proper patients, has moved one step closer to the US market with a new partnership.
by Leonora Beck
Danish diagnostics company Medical Prognosis Institute (MPI) is building on its business foundation with a new American alliance. MPI has signed a collaboration agreement with Arizona-based cancer research outfit TD2, which is planning to intergrate MPI’s diagnostic technology in its platform.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
